Diabetes, glycaemia, and cognition-a secondary analysis of the Finnish Diabetes Prevention Study

Diabetes/Metabolism Research and Reviews

Volumn 32, Issue 1, 2016, Pages 102-110

  Lehtisalo, Jenni ^a,b   Lindström, Jaana ^a   Ngandu, Tiia ^a   Kivipelto, Miia ^a,c,d   Ahtiluoto, Satu ^a,e   Ilanne Parikka, Pirjo ^f,g   Keinänen Kiukaanniemi, Sirkka ^h,i   Eriksson, Johan G ^a,b,j,k   Uusitupa, Matti ^d,l   Tuomilehto, Jaakko ^m,n,o   Luchsinger, Jose A ^p  

^a NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

^c KAROLINSKA INSTITUTE   (Sweden)

^d UNIVERSITY OF EASTERN FINLAND   (Finland)

^e City of Espoo Information Management Center   (Finland)

^f TAMPERE UNIVERSITY HOSPITAL   (Finland)

^g Finnish Diabetes Association   (Finland)

^h UNIVERSITY OF OULU   (Finland)

ⁱ OULU UNIVERSITY HOSPITAL   (Finland)

^j FOLKHÄLSAN RESEARCH CENTER   (Finland)

^k HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^l KUOPIO UNIVERSITY HOSPITAL   (Finland)

^m DANUBE UNIVERSITY KREMS   (Austria)

ⁿ HOSPITAL UNIVERSITARIO LA PAZ IDIPAZ   (Spain)

^o KING ABDULAZIZ UNIVERSITY   (Saudi Arabia)

^p Department of Medicine   (United States)

more..

Author keywords

Cognition; Dysglycaemia; Type 2 diabetes

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C;

ADULT; ARTICLE; COGNITION; CONSORTIUM TO ESTABLISH A REGISTRY FOR ALZHEIMER DISEASE TEST; CONTROLLED STUDY; DIABETES MELLITUS; EXECUTIVE FUNCTION TEST; FEMALE; FINLAND; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HUMAN; IMPAIRED GLUCOSE TOLERANCE; LIFESTYLE MODIFICATION; MAJOR CLINICAL STUDY; MALE; OBESITY; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); TRAIL MAKING TEST; AGED; AGING; BODY MASS; CLINICAL TRIAL; COGNITIVE DYSFUNCTION; COHORT ANALYSIS; COMPLICATION; CROSS-SECTIONAL STUDY; DIABETES MELLITUS, TYPE 2; DISEASE COURSE; EARLY TERMINATION OF CLINICAL TRIAL; FOLLOW UP; LIFESTYLE; MIDDLE AGED; MULTICENTER STUDY; MULTIMODALITY CANCER THERAPY; OVERWEIGHT; PATHOPHYSIOLOGY; PATIENT COMPLIANCE; PREDIABETIC STATE; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR;

ADULT; AGED; AGING; BODY MASS INDEX; COGNITIVE DYSFUNCTION; COHORT STUDIES; COMBINED MODALITY THERAPY; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; DISEASE PROGRESSION; EARLY TERMINATION OF CLINICAL TRIALS; FEMALE; FINLAND; FOLLOW-UP STUDIES; HUMANS; LIFE STYLE; MALE; MIDDLE AGED; OVERWEIGHT; PATIENT COMPLIANCE; PREDIABETIC STATE; RISK FACTORS;

EID: 84953836387     PISSN: 15207552     EISSN: 15207560     Source Type: Journal    
DOI: 10.1002/dmrr.2679     Document Type: Article

References (42)

1. Vagelatos NT, Eslick GD. Type 2 diabetes as a risk factor for Alzheimer's disease: the confounders, interactions, and neuropathology associated with this relationship. Epidemiol Rev 2013; 35: 152-156. DOI:10.1093/epirev/mxs012.
2. McCrimmon RJ, Ryan CM, Frier BM. Diabetes and cognitive dysfunction. Lancet 2012; 379(9833): 2291-2299. DOI:10.1016/S0140-6736(12)60360-2.
3. Exalto LG, Whitmer RA, Kappele LJ, et al. An update on type 2 diabetes, vascular dementia and Alzheimer's disease. Exp Gerontol 2012; 47(11): 858-864. DOI:10.1016/j.exger.2012.07.014.
4. Debling D, Amelang M, Hasselbach P, et al. Diabetes and cognitive function in a population-based study of elderly women and men. J Diabetes Complications 2006; 20(4): 238-245. DOI:10.1016/j.jdiacomp.2005.06.016.
5. Kumari M, Marmot M. Diabetes and cognitive function in a middle-aged cohort: findings from the Whitehall II study. Neurology 2005; 65(10): 1597-1603. DOI:10.1212/01.wnl.0000184521.80820.e4.
6. Yaffe K, Blackwell T, Kanaya AM, et al. Diabetes, impaired fasting glucose, and development of cognitive impairment in older women. Neurology 2004; 63(4): 658-663.
7. Ryan CM, Geckle M. Why is learning and memory dysfunction in Type 2 diabetes limited to older adults? Diabetes Metab Res Rev 2000; 16(5): 308-315.
8. Luchsinger JA, Palmas W, Teresi JA, et al. Improved diabetes control in the elderly delays global cognitive decline. J Nutr Health Aging 2011; 15(6): 445-449.
9. Baker LD, Frank LL, Foster-Schubert K, et al. Aerobic exercise improves cognition for older adults with glucose intolerance, a risk factor for Alzheimer's disease. J Alzheimers Dis 2010; 22(2): 569-579. DOI:10.3233/JAD-2010-100768.
10. Luchsinger JA. Type 2 diabetes and cognitive impairment: linking mechanisms. J Alzheimer's Dis 2012; 30: S185-198. DOI:10.3233/JAD-2012-111433.
11. Strachan MW, Reynolds RM, Marioni RE, et al. Cognitive function, dementia and type 2 diabetes mellitus in the elderly. Nat Rev Endocrinol 2011; 7(2): 108-114. DOI:10.1038/nrendo.2010.228.
12. Tuomilehto J, Lindström J, Eriksson JG, et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001; 344(18): 1343-1350.
13. Luchsinger JA, Lehtisalo J, Lindström J, et al. Cognition in the Finnish Diabetes Prevention Study. Diabetes Res Clin Pract 2015; 108(3): e63-e66. DOI:10.1016/j.diabres.2015.02.023.
14. Eriksson J, Lindström J, Valle T, et al. Prevention of Type II diabetes in subjects with impaired glucose tolerance: the Diabetes Prevention Study (DPS) in Finland. Study design and 1-year interim report on the feasibility of the lifestyle intervention programme. Diabetologia 1999; 42(7): 793-801.
15. World Health Organization. Diabetes mellitus: report of a WHO study group. WHO Tech Rep Ser 1985; 727: 7-113.
16. Lehtovirta M, Soininen H, Helisalmi S, et al. Clinical and neuropsychological characteristics in familial and sporadic Alzheimer's disease: relation to apolipoprotein E polymorphism. Neurology 1996; 46(2): 413-419.
17. Morris JC, Heyman A, Mohs RC, et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part I. Clinical and neuropsychological assessment of Alzheimer's disease. Neurology 1989; 39(9): 1159-1165.
18. Reitan RM. The relation of the trail making test to organic brain damage. J Consult Psychol 1955; 19(5): 393-394.
19. Chandler MJ, Lacritz LH, Hynan LS, et al. A total score for the CERAD neuropsychological battery. Neurology 2005; 65(1): 102-106. DOI:10.1212/01.wnl.0000167607.63000.38.
20. Box GEP, Cox DR. An analysis of transformations. J R Stat Soc 1964; 26: 211-252.
21. World Health Organization. Definition, Diagnosis and Classification of Diabetes Mellitus and its Complications: Report of a WHO Consultation. Part 1: diagnosis and classification of diabetes mellitus. 1999.
22. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2010; 33(Suppl 1): S62-S69. DOI:10.2337/dc10-S062.
23. Mayeda ER, Haan MN, Kanaya AM, et al. Type 2 diabetes and 10-year risk of dementia and cognitive impairment among older Mexican Americans. Diabetes Care 2013; 36(9): 2600-2606. DOI:10.2337/dc12-2158.
24. Cheng G, Huang C, Deng H, et al. Diabetes as a risk factor for dementia and mild cognitive impairment: a meta-analysis of longitudinal studies. Intern Med J 2012; 42(5): 484-491. DOI:10.1111/j.1445-5994.2012.02758.x.
25. Creavin ST, Gallacher J, Bayer A, et al. Metabolic syndrome, diabetes, poor cognition, and dementia in the Caerphilly prospective study. J Alzheimers Dis 2012; 28(4): 931-939. DOI:10.3233/JAD-2011-111550.
26. Cheng D, Noble J, Tang MX, et al. Type 2 diabetes and late-onset Alzheimer's disease. Dement Geriatr Cogn Disord 2011; 31(6): 424-430. DOI:10.1159/000324134.
27. Xu W, Qiu C, Gatz M, et al. Mid- and late-life diabetes in relation to the risk of dementia: a population-based twin study. Diabetes 2009; 58(1): 71-77. DOI:10.2337/db08-0586.
28. Yaffe K, Falvey C, Hamilton N, et al. Diabetes, glucose control, and 9-year cognitive decline among older adults without dementia. Arch Neurol 2012; 69(9): 1170-1175. DOI:10.1001/archneurol.2012.1117.
29. Spauwen PJ, Kohler S, Verhey FR, et al. Effects of type 2 diabetes on 12-year cognitive change: results from the Maastricht aging study. Diabetes Care 2013; 36(6): 1554-1561. DOI:10.2337/dc12-0746.
30. Paile-Hyvarinen M, Raikkonen K, Kajantie E, et al. Impact of glucose metabolism and birth size on cognitive performance in elderly subjects. Diabetes Res Clin Pract 2009; 83(3): 379-386. DOI:10.1016/j.diabres.2008.12.010.
31. Gregg EW, Yaffe K, Cauley JA, et al. Is diabetes associated with cognitive impairment and cognitive decline among older women? Study of Osteoporotic Fractures Research Group. Arch Intern Med 2000; 160(2): 174-180.
32. Nooyens AC, Baan CA, Spijkerman AM, et al. Type 2 diabetes and cognitive decline in middle-aged men and women: the Doetinchem Cohort Study. Diabetes Care 2010; 33(9): 1964-1969. DOI:10.2337/dc09-2038.
33. van den Berg E, Reijmer YD, de Bresser J, et al. A 4 year follow-up study of cognitive functioning in patients with type 2 diabetes mellitus. Diabetologia 2010; 53(1): 58-65. DOI:10.1007/s00125-009-1571-9.
34. Fontbonne A, Berr C, Ducimetiere P, et al. Changes in cognitive abilities over a 4-year period are unfavorably affected in elderly diabetic subjects: results of the Epidemiology of Vascular Aging Study. Diabetes Care 2001; 24(2): 366-370.
35. Duff K, Lyketsos CG, Beglinger LJ, et al. Practice effects predict cognitive outcome in amnestic mild cognitive impairment. Am J Geriatr Psychiatry 2011; 19(11): 932-939. DOI:10.1097/JGP.0b013e318209dd3a.
36. Crane PK, Walker R, Hubbard RA, et al. Glucose levels and risk of dementia. N Engl J Med 2013; 369(6): 540-548. DOI:10.1056/NEJMoa1215740.
37. Lehtisalo J, Lindström J, Ngandu T, et al. Association of long-term dietary fat intake, exercise, and weight with later cognitive function in the Finnish Diabetes Prevention Study. J Nutr Health Aging [accepted for publication).
38. Mortby ME, Janke AL, Anstey KJ, et al. High "normal" blood glucose is associated with decreased brain volume and cognitive performance in the 60s: the PATH through life study. PLoS One 2013; 8(9): e73697. DOI:10.1371/journal.pone.0073697.
39. Tolppanen AM, Lavikainen P, Solomon A, et al. History of medically treated diabetes and risk of Alzheimer disease in a nationwide case-control study. Diabetes Care 2013; 36(7): 2015-2019. DOI:10.2337/dc12-1287.
40. Ruusunen A, Voutilainen S, Karhunen L, et al. How does lifestyle intervention affect depressive symptoms? Results from the Finnish Diabetes Prevention Study. Diabet Med 2012; 29(7): e126-32. DOI:10.1111/j.1464-5491.2012.03602.x.
41. Saaristo T, Barengo N, Korpi-Hyovalti E, et al. High prevalence of obesity, central obesity and abnormal glucose tolerance in the middle-aged Finnish population. BMC Public Health 2008; 8(1): 423. DOI:10.1186/1471-2458-8-423.
42. Centers for Disease Control And Prevention. In National Diabetes Statistics Report: Estimates of Diabetes and its Burden in the United States. U.S. Department of Health and Human Services: Atlanta, GA, 2014.